Laman Utama000100 • KRX
add
Yuhan Corp
Tutup sebelumnya
₩115,900.00
Julat hari
₩114,900.00 - ₩117,000.00
Julat tahun
₩68,400.00 - ₩166,900.00
Permodalan pasaran
9.34T KRW
Bilangan Purata
763.17K
Nisbah P/E
121.94
Hasil dividen
0.43%
Berita pasaran
Invezz
17 jam lalu
Amaran risiko: ‘kemelesetan sederhana’ boleh menjejaskan tahap S&P 500 kepada 3,700
0.74%
0.050%
0.83%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 496.10B | 13.49% |
Perbelanjaan pengendalian | 158.12B | 25.16% |
Pendapatan bersih | -11.51B | -113.43% |
Margin untung bersih | -2.32 | -111.84% |
Pendapatan bagi setiap syer | -154.00 | -113.90% |
EBITDA | 4.68B | -73.81% |
Kadar cukai berkesan | 45.58% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 330.70B | 2.70% |
Jumlah aset | 2.94T | 4.61% |
Jumlah liabiliti | 791.38B | 11.20% |
Jumlah ekuiti | 2.15T | — |
Syer tertunggak | 75.00J | — |
Harga kepada buku | 4.14 | — |
Pulangan pada aset | -1.01% | — |
Pulangan pada modal | -1.21% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -11.51B | -113.43% |
Tunai daripada operasi | 53.53B | -8.74% |
Tunai daripada pelaburan | -19.08B | 65.62% |
Tunai daripada pembiayaan | 37.54B | 38.14% |
Perubahan bersih dalam tunai | 76.62B | 192.15% |
Aliran tunai bebas | -3.16B | 85.62% |
Perihal
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Diasaskan
1926
Tapak web
Pekerja
1,994
